Global Cell and Gene Therapy Manufacturing Industry is projected to surpass a valuation of US$ 240 Billion by 2033, according to FMI’s analysis

The cell and gene therapy manufacturing industry is poised for unprecedented growth, with Future Market Insights forecasting a staggering Compound Annual Growth Rate (CAGR) of 29% from 2023 to 2033. The global market, which reached a valuation of approximately US$ 19.3 Billion in 2023, is projected to soar to an estimated US$ 240 Billion by …

Global Cell and Gene Therapy Manufacturing Industry is projected to surpass a valuation of US$ 240 Billion by 2033 expedition as per FMI

The global cell and gene therapy manufacturing industry size is anticipated to create phenomenal growth opportunities over the forecast period by registering a CAGR of 29% from 2023 to 2033. The global market reached a valuation of around US$ 19.3 Billion in 2023 and is expected to surpass a valuation of around US$ 240 Billion …